C60 Evo, founded in 2019, operates at the intersection of the Health and Wellness and Sports industries. Based in the United States, the company offers a unique product lineup centered around ESS60, an advanced version of carbon fullerenes. Originally crafted in their lab, which has been a leader in carbon 60 fullerene production since 1991, C60 Evo distinguished itself by delivering to the historic "2012 Paris Baati Study," which found significant longevity benefits.
The company boasts a diverse range of products such as edible oils, skin serums, a peptide-infused hair re-growth formula, and lip balms—all formulated with ESS60. C60 Evo stands out as the sole provider of pure ESS60 for consumer use, positioning itself distinctively in a market where industrial-grade C60 predominates. Despite currently having no recorded investment rounds, C60 Evo presents a promising opportunity for investors looking to enter an innovative, science-backed sector featuring revolutionary wellness products.